Salvia leriifolia
Salvia leriifolia · Accepted scientific name
Scientific literature: Very Sparse (4 studies) · ★☆☆☆☆
Salvia leriifolia is a plant species that holds significant pharmacological potential due to its diverse biological activities. Research indicates that extracts from its leaves and roots, particularly the n-hexane and root extracts, exhibit cytotoxic, antimicrobial, and antiprotozoal properties. A key chemical constituent identified in this plant is pisiferal, which contributes to its therapeutic profile. Studies have explored its effectiveness against challenging conditions such as Leishmania donovani, Plasmodium falciparum, and Trypanosoma brucei rhodesiense. Furthermore, the plant shows promise in addressing complex health issues like morphine dependence.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Lamiaceae
- Distribution
- Not available
- Plant Parts
- Root · Leaf
Classification
Taxonomy
Salvia leriifolia belongs to the vast kingdom Plantae, representing a diverse group of multicellular organisms. Within this kingdom, the species is classified under the class Equisetopsida, which encompasses many well-known flowering plants. It further falls into the order Lamiales, a group known for its distinct botanical characteristics. As a member of the family Lamiaceae, it shares common traits with other aromatic herbs like mint and basil. Ultimately, this plant is defined by its placement within the prominent genus Salvia.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Lamiales |
| Family | Lamiaceae |
| Genus | Salvia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Salvia leriifolia is a notable species found primarily within the Asia-Temperate region. Its natural distribution encompasses the rugged landscapes of Western Asia, stretching across diverse terrains. Specifically, this plant can be located throughout the country of Afghanistan. Furthermore, its presence extends significantly into the territory of Iran. These geographic connections highlight the plant's specific ecological niche within the Western Asian continent.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Salvia leriifolia is a self-supporting plant that maintains its own structure without the need for external assistance.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Salvia leriifolia has demonstrated significant therapeutic potential through the isolation of various bioactive diterpenoids. Research indicates that the plant possesses potent cytotoxic activities, particularly against multiple human cancer cell lines such as MCF-7 and HeLa. Furthermore, the species exhibits notable antimicrobial properties, showing effectiveness against both gram-positive and gram-negative bacteria including methicillin-resistant S. aureus. The plant's chemical profile also includes compounds with impressive antiprotozoal activity against pathogens like Plasmodium falciparum and Trypanosoma brucei. These diverse biological activities highlight the importance of studying Salvia leriifolia for the development of new medicinal agents.
Compounds
Salvia leriifolia is an endemic plant from Iran that has become a subject of significant phytochemical interest. Recent investigations into its root extracts have successfully isolated sixteen different abietane diterpenoids. Among these identified substances, the known diterpene pisiferal was specifically highlighted for its biological activity. Research indicates that pisiferal exhibits high cytotoxicity across several tested cell lines, including AGS, HeLa, and MCF-7. This discovery underscores the potential medicinal value held within the chemical profile of Salvia leriifolia.
Conditions
Salvia leriifolia exhibits significant therapeutic potential through its ability to treat various human cancer cell lines. Specifically, its labdane diterpenoids demonstrate cytotoxic activity against DU-145 human prostate cancer cells, as well as MCF-7 and MDA-MB231 human breast cancer cells. Beyond oncology, the plant contains rearranged abietane diterpenoids that serve as effective antiprotozoal agents. These compounds are capable of treating Leishmania donovani and Plasmodium falciparum. Through these diverse biological activities, the plant shows promise in addressing both malignant tumors and parasitic infections.
Preparations
Salvia leriifolia is prepared as an n-hexane extract of its aerial parts to isolate various labdane diterpenoids. This specific extraction method allowed researchers to identify both new and known compounds for antimicrobial and cytotoxic testing. Additionally, Salvia leriifolia is prepared as a root extract to facilitate phytochemical profiling. Through this root extraction, sixteen abietane diterpenes were successfully isolated for further structural elucidation. These diverse preparation methods enable the study of different chemical constituents within the plant.
Parts used
Salvia leriifolia is a plant species that offers significant pharmacological potential through its various anatomical parts. Research into the roots of this plant has led to the isolation of unique abietane diterpenoids with promising antiprotozoal and antimalarial activities. Additionally, phytochemical profiling of the root extracts has identified several original compounds that demonstrate cytotoxicity against various cancer cell lines. Beyond its roots, the leaves of the plant also provide important medicinal benefits. Specifically, leaf extracts have been shown to effectively reduce morphine withdrawal symptoms in animal models, acting with an efficacy comparable to certain sedative medications.